Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act regarding changes in number of votes
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 26 July, 2011 at 5.00 p.m.
Notification according to Chapter 2, Section 10 of the Finnish Securities Market
Act regarding changes in number of votes
Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of a
notification regarding changes in number of votes in accordance with Chapter 2,
Section 9 of the Finnish Securities Markets Act, described below.
The notification received by the Company concerns the changes in voting rights
of Abingworth Management Limited (through Abingworth Bioventures IV LP and
Abingworth Bioventures IV Executives LP) in the Company. The holdings of shares
in the Company by Abingworth Management Limited (through Abingworth Bioventures
IV LP and Abingworth Bioventures IV Executives LP) continue to be below 1/20, as
previously.
As a result of the changes in the number of voting rights announced on 18 March
2011, 6 June 2011 and 7 July 2011 the number of votes in the Company by
Abingworth Management Limited (through Abingworth Bioventures IV LP and
Abingworth Bioventures IV Executives LP) has decreased below 1/20.
Name Number of Number of Number of (%) of Number of (%) of
shares voting shares shares voting voting
before rights after after rights rights
before after after
Abingworth
Management
Limited 16.693.258 16.693.258 16.693.258 4.66 16.693.258 4.66
(through
Abingworth
Bioventures
IV LP and
Abingworth
Bioventures
IV Executives
LP) in total
The number of voting rights and percentages presented above are calculated
without taking into account the treasury shares held by the Company or its group
companies.
On the date hereof, the registered number of shares in Biotie is 387,594,457. Of
these shares 11,880,224 are held by the Company or its group companies.
Turku, 26 July 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1533503]
Unternehmensinformation / Kurzprofil:
Datum: 26.07.2011 - 16:00 Uhr
Sprache: Deutsch
News-ID 56720
Anzahl Zeichen: 3185
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act regarding changes in number of votes"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
